Lupin Achieves Significant Milestone with ISO 14001 & ISO 45001 Certification in India
Lupin achieves significant milestone with ISO 14001 & ISO 45001 certification across all its Indian manufacturing sites, R&D centre and corporate office
Overview
pharma major Lupin Limited (Lupin) announced that all 12 of its manufacturing sites, its R&D Centre and corporate office in India have successfully completed rigorous audits and been certified by DNV for ISO 14001 — Environment Management Systems (EMS), and ISO 45001 — Occupational Health and Safety Management System (OHSMS). This achievement marks a significant milestone in acknowledging Lupin’s commitment to safe and sustainable operations.
ISO 14001
ISO 14001 is an internationally recognized standard for Environmental Management Systems.
This certification demonstrates Lupin’s dedication to minimizing its environmental footprint and fostering sustainable practices across its operations.
The ISO 45001 certification underscores Lupin’s unwavering commitment to ensuring the health, safety and well-being of its employees and stakeholders.
Words from MD: Lupin
Commenting on this remarkable achievement, Nilesh Gupta, managing director, Lupin, said, “We are very proud of this achievement; it acknowledges our steadfast commitment to excellence in environmental stewardship and workplace safety and is a reflection of our ongoing efforts to integrate sustainable practices into our business operations and prioritize the health and safety of our people.”
Lupin
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.
The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.